27 MAY 2010

NEW ZEALAND GAZETTE, No. 60

1721

Product: Exjade
Active Ingredient: Deferasirox 250mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Note: This consent is valid for two years from the date of publication of this notice.

Product: Exjade
Active Ingredient: Deferasirox 500mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Note: This consent is valid for two years from the date of publication of this notice.

Product: Taxotere
Active Ingredient: Docetaxel trihydrate 40mg/mL
Dosage Form: Solution for Concentrate for infusion
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers:

• Sanofi Chimie, Vitry-Sur-Seine, France
• Aventis Pharma, Essex, United Kingdom
• Pierre Fabre Medicament Production, Idron, France
  Note: This consent is valid for two years from the date of publication of this notice.

Dated this 21st day of May 2010.

ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go3983

Provisional Consent to the Distribution of New Medicines

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Atenolol tablets, USP
Active Ingredient: Atenolol 50mg
Dosage Form: Tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Pharmaceuticals Inc, Morgantown, United States of America
Note: This consent is valid for two years from the date of publication of this notice.

Product: Atenolol tablets, USP
Active Ingredient: Atenolol 100mg
Dosage Form: Tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Pharmaceuticals Inc, Morgantown, United States of America
Note: This consent is valid for two years from the date of publication of this notice.

Dated this 24th day of May 2010.

MARK RICHARDS, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go4050

New Zealand Public Health and Disability Act 2000

Reappointments and Appointments to the Upper South A Regional Ethics Committee

Pursuant to section 11 of the New Zealand Public Health and Disability Act 2000, I reappoint

• Carolynn Bull as a lawyer member
• Russell Scott as a health practitioner member

of the Upper South A Regional Ethics Committee for one-year terms of office commencing on the date of this notification; and

• Jane Ward as a health researcher member

of the Upper South A Regional Ethics Committee for a two-year term of office commencing on the date of this notification; and appoint

• Angelika Frank-Alexander as a community representative member
• Christine Robertson as a health practitioner member

of the Upper South A Regional Ethics Committee for three-year terms of office commencing on the date of this notification.

Dated at Hamilton this 15th day of May 2010.

HON TONY RYALL, Minister of Health.

go3927